BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Tuesday 23 May 2017
Interview with BioLargo, Inc. CEO Dennis Calvert on Uptick Network
Dennis Calvert, President and CEO of BioLargo, Inc. was interviewed by Everett Jolly of Uptick Network on the progress of BioLargo's technology platforms - the Advanced Oxidation System (AOS) water treatment system, advanced industrial odor control solution CupriDyne Clean, and Clyra advanced wound care technologies.
He discusses the company's recent commercial successes in the industrial odor control market, including the recent execution of national purchasing agreements with leading companies in the industry, and Clyra Medical and its plans to file a 510(k) with two fully developed wound care products in the June - July time frame.
For a direct link to the interview, go to Uptick Network.
Note that in the interview he references the Waste360 report describing the top 10 companies in the USA. See this link to view that article.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment